BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31683487)

  • 1. Granisetron Alleviates Alzheimer's Disease Pathology in TgSwDI Mice Through Calmodulin-Dependent Protein Kinase II/cAMP-Response Element Binding Protein Pathway.
    Al Rihani SB; Lan RS; Kaddoumi A
    J Alzheimers Dis; 2019; 72(4):1097-1117. PubMed ID: 31683487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-Brain Barrier Disruption Increases Amyloid-Related Pathology in TgSwDI Mice.
    Abdallah IM; Al-Shami KM; Yang E; Kaddoumi A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oleocanthal enhances amyloid-β clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model.
    Qosa H; Batarseh YS; Mohyeldin MM; El Sayed KA; Keller JN; Kaddoumi A
    ACS Chem Neurosci; 2015 Nov; 6(11):1849-59. PubMed ID: 26348065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive improvement and synaptic deficit attenuation by a multifunctional carbazole-based cyanine in AD mice model through regulation of Ca
    Chen C; Xu D; Zhang ZH; Jia SZ; Cao XC; Chen YB; Song GL; Wong MS; Li HW
    Exp Neurol; 2020 May; 327():113210. PubMed ID: 31987831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oleocanthal-Rich Extra-Virgin Olive Oil Restores the Blood-Brain Barrier Function through NLRP3 Inflammasome Inhibition Simultaneously with Autophagy Induction in TgSwDI Mice.
    Al Rihani SB; Darakjian LI; Kaddoumi A
    ACS Chem Neurosci; 2019 Aug; 10(8):3543-3554. PubMed ID: 31244050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Hit Compounds Identified from High-throughput Screening for their Effect on Blood-brain Barrier Integrity and Amyloid-β Clearance: In Vitro and In Vivo Studies.
    Elfakhri KH; Duong QV; Langley C; Depaula A; Mousa YM; Lebeouf T; Cain C; Kaddoumi A
    Neuroscience; 2018 May; 379():269-280. PubMed ID: 29596966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. κ‑opioid receptor agonist, U50488H, inhibits pyroptosis through NLRP3 via the Ca
    Song X; Cui Z; He J; Yang T; Sun X
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crocus sativus Extract Tightens the Blood-Brain Barrier, Reduces Amyloid β Load and Related Toxicity in 5XFAD Mice.
    Batarseh YS; Bharate SS; Kumar V; Kumar A; Vishwakarma RA; Bharate SB; Kaddoumi A
    ACS Chem Neurosci; 2017 Aug; 8(8):1756-1766. PubMed ID: 28471166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking the apolipoprotein E/amyloid-β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice.
    Yang J; Ji Y; Mehta P; Bates KA; Sun Y; Wisniewski T
    J Alzheimers Dis; 2011; 24(2):269-85. PubMed ID: 21239853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of α7 nAChR by PNU-282987 improves synaptic and cognitive functions through restoring the expression of synaptic-associated proteins and the CaM-CaMKII-CREB signaling pathway.
    Wang XL; Deng YX; Gao YM; Dong YT; Wang F; Guan ZZ; Hong W; Qi XL
    Aging (Albany NY); 2020 Jan; 12(1):543-570. PubMed ID: 31905173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Synthetic Coumarin-Chalcone Derivative (E)-3-(3-(4-(Dimethylamino)Phenyl)Acryloyl)-4-Hydroxy-2
    Chiu YJ; Lin TH; Chen CM; Lin CH; Teng YS; Lin CY; Sun YC; Hsieh-Li HM; Su MT; Lee-Chen GJ; Lin W; Chang KH
    Oxid Med Cell Longev; 2021; 2021():3058861. PubMed ID: 34812274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-faceted therapeutic strategy for treatment of Alzheimer's disease by concurrent administration of etodolac and α-tocopherol.
    Elfakhri KH; Abdallah IM; Brannen AD; Kaddoumi A
    Neurobiol Dis; 2019 May; 125():123-134. PubMed ID: 30710675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleocanthal-rich extra-virgin olive oil enhances donepezil effect by reducing amyloid-β load and related toxicity in a mouse model of Alzheimer's disease.
    Batarseh YS; Kaddoumi A
    J Nutr Biochem; 2018 May; 55():113-123. PubMed ID: 29413486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics.
    Singh CSB; Choi KB; Munro L; Wang HY; Pfeifer CG; Jefferies WA
    EBioMedicine; 2021 Sep; 71():103503. PubMed ID: 34534764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling.
    Kook SY; Hong HS; Moon M; Ha CM; Chang S; Mook-Jung I
    J Neurosci; 2012 Jun; 32(26):8845-54. PubMed ID: 22745485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angelica tenuissima Nakai Ameliorates Cognitive Impairment and Promotes Neurogenesis in Mouse Model of Alzheimer's Disease.
    Choi M; Lee Y; Cho SH
    Chin J Integr Med; 2018 May; 24(5):378-384. PubMed ID: 28578486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Throughput Screening for Identification of Blood-Brain Barrier Integrity Enhancers: A Drug Repurposing Opportunity to Rectify Vascular Amyloid Toxicity.
    Qosa H; Mohamed LA; Al Rihani SB; Batarseh YS; Duong QV; Keller JN; Kaddoumi A
    J Alzheimers Dis; 2016 Jul; 53(4):1499-516. PubMed ID: 27392852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCM-198 Ameliorates Cognitive Deficits, Promotes Neuronal Survival and Enhances CREB/BDNF/TrkB Signaling without Affecting Aβ Burden in AβPP/PS1 Mice.
    Hong ZY; Yu SS; Wang ZJ; Zhu YZ
    Int J Mol Sci; 2015 Aug; 16(8):18544-63. PubMed ID: 26262618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IVIG immunotherapy protects against synaptic dysfunction in Alzheimer's disease through complement anaphylatoxin C5a-mediated AMPA-CREB-C/EBP signaling pathway.
    Gong B; Pan Y; Zhao W; Knable L; Vempati P; Begum S; Ho L; Wang J; Yemul S; Barnum S; Bilski A; Gong BY; Pasinetti GM
    Mol Immunol; 2013 Dec; 56(4):619-29. PubMed ID: 23911420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain Penetrating Bifunctional Erythropoietin-Transferrin Receptor Antibody Fusion Protein for Alzheimer's Disease.
    Chang R; Al Maghribi A; Vanderpoel V; Vasilevko V; Cribbs DH; Boado R; Pardridge WM; Sumbria RK
    Mol Pharm; 2018 Nov; 15(11):4963-4973. PubMed ID: 30252487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.